st 679 has been researched along with piroxicam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderloni, A; Bianchi Porro, G; Lazzaroni, M | 1 |
| Belogi, L; Mezzadri, CM; Tubaro, E | 1 |
1 trial(s) available for st 679 and piroxicam
| Article | Year |
|---|---|
The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Duodenum; Endoscopy; Female; Gastric Mucosa; Glycine; Humans; Intestinal Mucosa; Male; Piroxicam; Pyrroles; Stomach | 2001 |
1 other study(ies) available for st 679 and piroxicam
| Article | Year |
|---|---|
Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Body Weight; Bone Density; Carrageenan; Dose-Response Relationship, Drug; Exudates and Transudates; Glycine; In Vitro Techniques; Indomethacin; Male; Piroxicam; Platelet Aggregation; Platelet Aggregation Inhibitors; Pleurisy; Pyrroles; Rats; Thromboxane B2 | 2001 |